Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCM Ultrasonic Atomization Treatment for Dry Eye Disease
NCT06089317Completed
- Sponsor
- The Chinese University of Hong Kong
- Start
- Jul 2024
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dendrobii caulis and Houttuynia cordata in dry eye disease (DED) (5 arms), sponsored by The Chinese University of Hong Kong. Primary endpoints: Ocular Surface Disease Index at 4 weeks and Non-invasive Tear Break-up Times at 4 weeks. Started Jul 2024; status: completed.
02
Drugs
dendrobii caulisHouttuynia cordata
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT06089317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06089317.